Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Oddou

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Expert Opinion on Investigational Drugs|January 5, 2002
Ongoing clinical trials in systemic hypertensionJ Mann, P Oddou
European Journal of Biochemistry|December 5, 1991
Identification and characterization of Heliothis virescens midgut membrane proteins binding Bacillus thuringiensis delta-endotoxinsP Oddou, H Hartmann, M Geiser
European Journal of Biochemistry|February 15, 1993
Immunologically unrelated Heliothis sp. and Spodoptera sp. midgut membrane-proteins bind Bacillus thuringiensis CryIA(b) delta-endotoxinP Oddou, H Hartmann, F Radecke, et al.
European Journal of Biochemistry|November 15, 1988
Monoclonal antibodies neutralizing mammalian DNA topoisomerase I activityP Oddou, U Schmidt, R Knippers, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|January 24, 1998
Valsartan: long-term efficacy and tolerability compared to lisinopril in elderly patients with essential hypertensionA D Bremner, M Baur, P Oddou-Stock, et al.
Clinical Therapeutics|January 23, 1999
Dose-responsive antihypertensive efficacy of valsartan, a new angiotensin II-receptor blockerJ Pool, S Oparil, T Hedner, et al.
The Journal of International Medical Research|November 1, 2003
Pulse pressure responses in patients treated with Valsartan and hydrochlorothiazide combination therapyR Carretta, P Trenkwalder, F Martinez, et al.
Journal of Hypertension|March 4, 2000
Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal DiseaseL M Ruilope, J C Aldigier, C Ponticelli, et al.
American Journal of Hypertension|May 8, 1999
A comparison of the angiotensin II antagonists valsartan and losartan in the treatment of essential hypertensionT Hedner, S Oparil, K Rasmussen, et al.
Journal of Hypertension|September 1, 1996
Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared with placebo and enalaprilN J Holwerda, R Fogari, P Angeli, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Expert Opinion on Investigational Drugs|January 5, 2002
Ongoing clinical trials in systemic hypertensionJ Mann, P Oddou
European Journal of Biochemistry|December 5, 1991
Identification and characterization of Heliothis virescens midgut membrane proteins binding Bacillus thuringiensis delta-endotoxinsP Oddou, H Hartmann, M Geiser
European Journal of Biochemistry|February 15, 1993
Immunologically unrelated Heliothis sp. and Spodoptera sp. midgut membrane-proteins bind Bacillus thuringiensis CryIA(b) delta-endotoxinP Oddou, H Hartmann, F Radecke, et al.
European Journal of Biochemistry|November 15, 1988
Monoclonal antibodies neutralizing mammalian DNA topoisomerase I activityP Oddou, U Schmidt, R Knippers, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|January 24, 1998
Valsartan: long-term efficacy and tolerability compared to lisinopril in elderly patients with essential hypertensionA D Bremner, M Baur, P Oddou-Stock, et al.
Clinical Therapeutics|January 23, 1999
Dose-responsive antihypertensive efficacy of valsartan, a new angiotensin II-receptor blockerJ Pool, S Oparil, T Hedner, et al.
The Journal of International Medical Research|November 1, 2003
Pulse pressure responses in patients treated with Valsartan and hydrochlorothiazide combination therapyR Carretta, P Trenkwalder, F Martinez, et al.
Journal of Hypertension|March 4, 2000
Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal DiseaseL M Ruilope, J C Aldigier, C Ponticelli, et al.
American Journal of Hypertension|May 8, 1999
A comparison of the angiotensin II antagonists valsartan and losartan in the treatment of essential hypertensionT Hedner, S Oparil, K Rasmussen, et al.
Journal of Hypertension|September 1, 1996
Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared with placebo and enalaprilN J Holwerda, R Fogari, P Angeli, et al.
Pageof 2